Prestige Consumer Healthcare Inc
NYSE:PBH
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
57
84.85
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PBH stock under the Base Case scenario is 77.13 USD. Compared to the current market price of 84.85 USD, Prestige Consumer Healthcare Inc is Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Prestige Consumer Healthcare Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PBH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Prestige Consumer Healthcare Inc
Balance Sheet Decomposition
Prestige Consumer Healthcare Inc
Current Assets | 380.7m |
Cash & Short-Term Investments | 51.5m |
Receivables | 163.5m |
Other Current Assets | 165.6m |
Non-Current Assets | 2.9B |
PP&E | 83.7m |
Intangibles | 2.8B |
Other Non-Current Assets | 6.7m |
Current Liabilities | 106.9m |
Accounts Payable | 31.2m |
Accrued Liabilities | 75.5m |
Other Current Liabilities | 195k |
Non-Current Liabilities | 1.5B |
Long-Term Debt | 1.1B |
Other Non-Current Liabilities | 426.5m |
Earnings Waterfall
Prestige Consumer Healthcare Inc
Revenue
|
1.1B
USD
|
Cost of Revenue
|
-497.5m
USD
|
Gross Profit
|
613.2m
USD
|
Operating Expenses
|
-287.8m
USD
|
Operating Income
|
325.4m
USD
|
Other Expenses
|
-119.4m
USD
|
Net Income
|
205.9m
USD
|
Free Cash Flow Analysis
Prestige Consumer Healthcare Inc
USD | |
Free Cash Flow | USD |
In Q2, Prestige Consumer Healthcare reported sales of $284 million, slightly down from last year, largely due to supply constraints for Clear Eyes. However, growth in their International segment and brands like Hydralyte helped offset this decline. They anticipate full-year revenues of $1.125 billion to $1.140 billion, with adjusted EPS expected between $4.40 and $4.46. The company is confident in achieving approximately 1% organic growth, aided by improvements in the Clear Eyes supply chain and strategic marketing initiatives. With a robust free cash flow forecast of over $240 million, they plan to continue share buybacks and focus on prudent capital deployment.
What is Earnings Call?
PBH Profitability Score
Profitability Due Diligence
Prestige Consumer Healthcare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Prestige Consumer Healthcare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
PBH Solvency Score
Solvency Due Diligence
Prestige Consumer Healthcare Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Prestige Consumer Healthcare Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PBH Price Targets Summary
Prestige Consumer Healthcare Inc
According to Wall Street analysts, the average 1-year price target for PBH is 89.59 USD with a low forecast of 81.81 USD and a high forecast of 99.75 USD.
Dividends
Current shareholder yield for PBH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PBH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 505 full-time employees. The company went IPO on 2005-02-10. The firm operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.
Contact
IPO
Employees
Officers
The intrinsic value of one PBH stock under the Base Case scenario is 77.13 USD.
Compared to the current market price of 84.85 USD, Prestige Consumer Healthcare Inc is Overvalued by 9%.